Inventor
JEFFREY J. LETOURNEAU
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07DHeterocyclic compounds31%
Y02ATechnologies for adaptation to climate change6%
PatentTitleYear
11,773,110Heterocycle amines and uses thereof202311,583,538Substituted pyrrolo[1,2-a]pyrazines and pyrrolo[1,2-a][1,4]diazepines as TREX1 inhibitors202311,306,098Substituted pyrrolo[1,2-a]pyrazines and pyrrolo[1,2-a][1,4]diazepines as TREX1 inhibitors202211,236,055Non-systemic TGR5 agonists202211,186,593Heterocycle amines and uses thereof2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2023Patents assigned to LIGAND PHARM INC (2)· patent assignee history
2021–2023Based in US· patent location history
2022–2023Patents assigned to VENENUM BIODESIGN LLC (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| VENENUM BIODESIGN LLC | 3 | 2022–2023 |
| LIGAND PHARM INC | 2 | 2021–2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2021–2023 |